Business Guggenheim Raises Price Target for ABIVAX Ahead of Key Data Release ABIVAX Société Anonyme (NASDAQ: ABVX) has garnered attention as a promising biotechnology stock, particularly ahead of significant data regarding its lead candidate, obefazimod. On... Editorial5 hours ago